Inhibikase Therapeutics, Inc. Share Price
IKTInhibikase Therapeutics, Inc. Stock Performance
Open $1.58 | Prev. Close $1.57 | Circuit Range N/A |
Day Range $1.55 - $1.62 | Year Range $1.33 - $4.20 | Volume 2,627 |
Average Traded $1.58 |
Inhibikase Therapeutics, Inc. Share Price Chart
About Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a non-receptor Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson's disease and gastrointestinal tract. The company is also developing IkT-001Pro, a prodrug of the anticancer agent imatinib mesylate to treat stable phase chronic myelogenous leukemia. Inhibikase Therapeutics, Inc. has research and development collaborations with Johns Hopkins University, Arizona State University, and Michigan State University; and a collaborative research and development agreement with Sphaera Pharma Pte. Ltd. The company was founded in 2008 and is based in Atlanta, Georgia.
Inhibikase Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $1.58 | $1.62 | +0.00% |
12-Nov-25 | $1.58 | $1.62 | -0.61% |
11-Nov-25 | $1.60 | $1.63 | -0.61% |
10-Nov-25 | $1.64 | $1.64 | +10.07% |
07-Nov-25 | $1.43 | $1.49 | +0.00% |
06-Nov-25 | $1.57 | $1.49 | -12.35% |
05-Nov-25 | $1.64 | $1.70 | +5.59% |
FAQs on Inhibikase Therapeutics, Inc. Share Price
Can I buy Inhibikase Therapeutics, Inc. shares in India?
What is the share price of Inhibikase Therapeutics, Inc.?
What is the 5 year returns of Inhibikase Therapeutics, Inc.?
What are the high & low stock price of Inhibikase Therapeutics, Inc. today?
What is the 52-week high and low of Inhibikase Therapeutics, Inc. stock?